FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1480699740> ?p ?o ?g. }

• W1480699740 abstract "Prostate cancer (PC) is the most common male malignancy in Western countries and the second most common urological malignancy (Knudsen & Vasioukhin, 2010). In 2008 the estimated new cases for PC in the European Union were 382.000 (Ferlay et al. 2010). The possibility of early detection is attractive to clinicians and potential patients in spite of the fact that until recently concrete evidence that screening would influence PC mortality was lacking (Schroder, 2010). There are many risk factors for PC occurrence. The family history, genetic and environmental factors and their interaction can contribute to develop PC (Colloca & Venturino, 2011). Other risk factors are age, ethnic-racial-geographic factors, named constitutional factors, though it is not possible to know what percentage of these neoplasms are a result of these risk factors (Ferris-i-Tortajada et al. 2011). The polymorphisms in genes associated with PC probably represent the most part of familial PC burden. The recent advances in genomic research have made it possible to identify several new genomic based biomarkers for PC. These markers are easy to measure and stable over time but only one biomarker, prostate specific antigen (PSA), is used in the clinical today (Aly et al. 2011). The PSA screening allows to detect PC years before the emergence of clinically evident disease, which usually represents locally advanced or metastatic cancer (Gjertson & Albertsen, 2011). Treatment options for advanced PC – including hormone ablation therapy, radiation and surgery – do not offer cure but delay the inevitable recurrence of the lethal hormone-refractory disease. Chemotherapy using available anticancer drugs, with the exception of the taxane drug docetaxel, for late stage PC does not offer any survival benefit. All of these treatments are costly and have significant side effects including impotence and incontinence, which negatively affect the quality of life of the patients. Prevention is an important strategy for limiting PC morbidity and mortality. Pharmacological and dietary interventions have potentials functions in reduction of incident cases and in inhibition of disease progression and recurrence (Silberstein & Parsons, 2010). 5-alpha reductase inhibitors remain the predominant therapy to reduce the future risk of a PC diagnosis. Dutasteride and finasteride are currently the only proven agents for PC risk reduction (Strope & Andriole, 2010). Among the potential dietary intervention efforts to use of the micro-nutrient selenium (Se) in PC clinical trials is emerging as an important highlight and the outcomes indicate that Se is a promising treatment. Furthermore, Se inhibits PC through multiple mechanisms, and it is beneficial in controlling the development of this disease (Abdulah" @default.
• W1480699740 created "2016-06-24" @default.
• W1480699740 creator A5011301639 @default.
• W1480699740 creator A5054118215 @default.
• W1480699740 creator A5063979460 @default.
• W1480699740 creator A5076267766 @default.
• W1480699740 date "2011-11-21" @default.
• W1480699740 modified "2023-10-01" @default.
• W1480699740 title "New Selenoderivatives as Antitumoral Agents" @default.
• W1480699740 cites W1963695395 @default.
• W1480699740 cites W1967969719 @default.
• W1480699740 cites W1969750877 @default.
• W1480699740 cites W1970008323 @default.
• W1480699740 cites W1970657655 @default.
• W1480699740 cites W1973116243 @default.
• W1480699740 cites W1973488859 @default.
• W1480699740 cites W1980359360 @default.
• W1480699740 cites W1982236221 @default.
• W1480699740 cites W1983405941 @default.
• W1480699740 cites W1984645836 @default.
• W1480699740 cites W1985147544 @default.
• W1480699740 cites W1988618317 @default.
• W1480699740 cites W1995612090 @default.
• W1480699740 cites W1996814718 @default.
• W1480699740 cites W2011043085 @default.
• W1480699740 cites W2012090952 @default.
• W1480699740 cites W2012859890 @default.
• W1480699740 cites W2018206934 @default.
• W1480699740 cites W2018716448 @default.
• W1480699740 cites W2018972980 @default.
• W1480699740 cites W2021646488 @default.
• W1480699740 cites W2025625911 @default.
• W1480699740 cites W2026042453 @default.
• W1480699740 cites W2026707626 @default.
• W1480699740 cites W2027054920 @default.
• W1480699740 cites W2033998354 @default.
• W1480699740 cites W2034383333 @default.
• W1480699740 cites W2037637519 @default.
• W1480699740 cites W2045111362 @default.
• W1480699740 cites W2049948050 @default.
• W1480699740 cites W2050460069 @default.
• W1480699740 cites W2056633004 @default.
• W1480699740 cites W2058306191 @default.
• W1480699740 cites W2059334541 @default.
• W1480699740 cites W2063075325 @default.
• W1480699740 cites W2063464308 @default.
• W1480699740 cites W2064412188 @default.
• W1480699740 cites W2064875522 @default.
• W1480699740 cites W2070204963 @default.
• W1480699740 cites W2073992878 @default.
• W1480699740 cites W2074769261 @default.
• W1480699740 cites W2076899826 @default.
• W1480699740 cites W2080115164 @default.
• W1480699740 cites W2080781301 @default.
• W1480699740 cites W2080913348 @default.
• W1480699740 cites W2084682008 @default.
• W1480699740 cites W2085256729 @default.
• W1480699740 cites W2088055166 @default.
• W1480699740 cites W2092710824 @default.
• W1480699740 cites W2093031388 @default.
• W1480699740 cites W2093154548 @default.
• W1480699740 cites W2094658190 @default.
• W1480699740 cites W2095382420 @default.
• W1480699740 cites W2101448730 @default.
• W1480699740 cites W2108165389 @default.
• W1480699740 cites W2112179183 @default.
• W1480699740 cites W2114511168 @default.
• W1480699740 cites W2118460197 @default.
• W1480699740 cites W2123295754 @default.
• W1480699740 cites W2127612243 @default.
• W1480699740 cites W2134841172 @default.
• W1480699740 cites W2134945219 @default.
• W1480699740 cites W2139900098 @default.
• W1480699740 cites W2140589418 @default.
• W1480699740 cites W2142276353 @default.
• W1480699740 cites W2146123833 @default.
• W1480699740 cites W2146252974 @default.
• W1480699740 cites W2151604134 @default.
• W1480699740 cites W2156979835 @default.
• W1480699740 cites W2159497139 @default.
• W1480699740 cites W2164070896 @default.
• W1480699740 cites W2164194457 @default.
• W1480699740 cites W2165444670 @default.
• W1480699740 cites W2169155816 @default.
• W1480699740 cites W2365220722 @default.
• W1480699740 cites W2391517904 @default.
• W1480699740 cites W3023435860 @default.
• W1480699740 cites W3146792095 @default.
• W1480699740 cites W46364339 @default.
• W1480699740 doi "https://doi.org/10.5772/26680" @default.
• W1480699740 hasPublicationYear "2011" @default.
• W1480699740 type Work @default.
• W1480699740 sameAs 1480699740 @default.
• W1480699740 citedByCount "0" @default.
• W1480699740 crossrefType "book-chapter" @default.
• W1480699740 hasAuthorship W1480699740A5011301639 @default.
• W1480699740 hasAuthorship W1480699740A5054118215 @default.
• W1480699740 hasAuthorship W1480699740A5063979460 @default.
• W1480699740 hasAuthorship W1480699740A5076267766 @default.
• W1480699740 hasBestOaLocation W14806997401 @default.

• next